
377: Melodrama at the FDA and the Pfizer-Novo bidding war
The Readout Loud
00:00
Can Novo grow without MetSera?
Elaine and Adam discuss Novo's pipeline, competitive pressures from Lilly, oral semaglutide prospects, and strategic needs for growth.
Play episode from 27:40
Transcript


